Higher Dose of Rekovelle in Oocyte Donors

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 28, 2021

Primary Completion Date

June 16, 2022

Study Completion Date

June 16, 2022

Conditions

IVF

Interventions

DRUG

Follitropin Delta, Recombinant

15 µg of follitropin delta will be administered subcutaneously daily

Trial Locations (1)

Instituto Valenciano de Infertilidad, Madrid

All Listed Sponsors

lead

IVI Madrid

OTHER

NCT04778358 - Higher Dose of Rekovelle in Oocyte Donors | Biotech Hunter | Biotech Hunter